(Q28264675)

2

0 references

T Yamaguchi

3

0 references

Y Kagami

4

0 references

Y Miki

5

0 references

K Yoshida

Cell Death & Differentiation

6

16

0 references

language of work or name

English

0 references

publication date

April 2010

0 references

published in

0 references

volume

17

0 references

issue

4

0 references

page(s)

689-98

0 references

cites work

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

The serine/threonine kinase Pim-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Duration of nuclear NF-kappaB action regulated by reversible acetylation

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Pim serine/threonine kinases regulate the stability of Socs-1 protein

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/CDD.2009.174

21 April 2017

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

Shaping the nuclear action of NF-kappaB

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

Delineation of prognostic biomarkers in prostate cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Inhibition of the NF-kappaB transcriptional activity by protein kinase A.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Post-translational modification of RelA(p65) NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

The survival kinases Akt and Pim as potential pharmacological targets

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Pim family kinases enhance tumor growth of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

The tumor suppressor activity of SOCS-1.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Activation of SAPK/JNK signaling by protein kinase Cdelta in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

Protein kinase C delta activates IkappaB-kinase alpha to induce the p53 tumor suppressor in response to oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021

The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha)

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.174

7 January 2021